Chronic Δ-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions

Neuropharmacology

Volumn 39, Issue 7, 2000, Pages 1331-1336

  Rubino, Tiziana ^a   Vigano', Daniela ^a   Massi, Paola ^a   Spinello, Maurizio ^a   Zagato, Elisabetta ^a   Giagnoni, Gabriella ^a   Parolaro, Daniela ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

cAMP accumulation; Central nervous system; Chronic treatment; PKA activity; 9 Tetrahydrocannabinol

Indexed keywords

CANNABINOID RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRONABINOL;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; ENZYME ACTIVITY; GLOBUS PALLIDUS; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN; BRAIN NEOPLASMS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG TOLERANCE; MALE; NEUROBLASTOMA; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROCANNABINOL; TUMOR CELLS, CULTURED;

EID: 0034101876     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00196-3     Document Type: Article

References (23)

1. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacological and Biochemical Behaviour. 46:1993;575-579.
2. Bidaut-Russel M., Devane W.A., Howlett A.C. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. Journal of Neurochemistry. 55:1990;21-26.
3. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
4. Calandra B., Portier M., Kerneis A., Delpech M., Carillon C., Le Fur G., Ferrara P., Shire D. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor. European Journal of Pharmacology. 374:1999;445-455.
5. Costa B., Parolaro D., Colleoni M. Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. European Journal of Pharmacology. 313:1996;17-24.
6. Dill J.A., Howlett C.A. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. Journal of Pharmacology and Experimental Therapeutics. 244:1988;1157-1163.
7. Fan F., Tao Q., Abood M.E., Martin B.R. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP-55,940 on adenylyl cyclase in the cerebellum of CP-55,940-tolerant mice. Brain Research. 706:1996;13-20.
8. Glass M., Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. Journal of Neuroscience. 17:1997;5327-5333.
9. Hutcheson D.M., Tzavara E.T., Smadja C., Valjent E., Roques B.P., Hanoune J., Maldonado R. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ-9-tetrahydrocannabinol. British Journal of Pharmacology. 125:1998;1567-1577.
10. Koh W.S., Crawford R.B., Kaminski N.E. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta-9-tetrahydrocannabinol (delta-9-THC). Biochemical Pharmacology. 53:1997;1477-1484.
11. Nestler E.J., Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Molecular Pharmacology. 33:1987;127-132.
12. Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Research. 616:1993;293-302.
13. Pacheco M.A., Ward S.J., Childers S.R. Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes. Journal of Neurochemistry. 62:1994;1773-1782.
14. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
15. 9-tetrahydrocannabinol treatment. Pharmacological and Biochemical Behaviour. 47:1994;33-40.
16. 9-tetrahydrocannabinol. Synapse. 30:1998;298-308.
17. 9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Molecular Brain Research. 46:1997;100-108.
18. 9-tetrahydrocannabinol. Pharmacological and Biochemical Behaviour. 51:1995;731-735.
19. Rubino T., Massi P., Patrini G., Venier I., Giagnoni G., Parolaro D. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study. NeuroReport. 5:1994;2493-2496.
20. Rubino T., Patrini G., Parenti M., Mass P., Parolaro D. Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Molecular Brain Research. 44:1997;191-197.
21. Shapira M., Gafni M., Sarne Y. Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells. Brain Research. 806:1988;26-35.
22. 35S]GTPγS autoradiography in rat brain. Journal of Neuroscience. 1:1996;8057-8066.
23. 9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions. Molecular Brain Research. 62:1998;141-149.